| TRIM7 ubiquitinates SARS-CoV-2 membrane protein to limit apoptosis and viral replication M Gonzalez-Orozco, H Tseng, A Hage, H Xia, P Behera, K Afreen, ... bioRxiv, 2024.06. 17.599107, 2024 | 2 | 2024 |
| Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism CJ Bills, H Xia, JYC Chen, J Yeung, BK Kalveram, D Walker, X Xie, ... Emerging Microbes & Infections 12 (1), 2209208, 2023 | 13 | 2023 |
| Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages H Xia, J Yeung, B Kalveram, CJ Bills, JYC Chen, C Kurhade, J Zou, ... Emerging microbes & infections 12 (1), e2161422, 2023 | 15 | 2023 |
| SARS-COV-2 Omicron variants conformationally escape a rare quaternary antibody binding mode J Goike, CL Hsieh, AP Horton, EC Gardner, L Zhou, F Bartzoka, N Wang, ... Communications Biology 6 (1), 1250, 2023 | 4 | 2023 |
| Omicron sars-cov-2 assay H Xia, X Xie, PY Shi US Patent App. 18/076,315, 2023 | | 2023 |
| CMPK2 restricts Zika virus replication by inhibiting viral translation JB Pawlak, JCC Hsu, H Xia, P Han, HW Suh, TL Grove, J Morrison, ... PLoS pathogens 19 (4), e1011286, 2023 | 7 | 2023 |
| AT-752 targets multiple sites and activities on the Dengue virus replication enzyme NS5 M Feracci, C Eydoux, V Fattorini, LL Bello, P Gauffre, B Selisko, ... Antiviral research 212, 105574, 2023 | 12 | 2023 |
| Low neutralization of SARS-CoV-2 Omicron BA. 2.75. 2, BQ. 1.1 and XBB. 1 by parental mRNA vaccine or a BA. 5 bivalent booster C Kurhade, J Zou, H Xia, M Liu, HC Chang, P Ren, X Xie, PY Shi Nature medicine 29 (2), 344-347, 2023 | 360 | 2023 |
| Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA. 1 infection C Kurhade, J Zou, H Xia, M Liu, Q Yang, M Cutler, D Cooper, A Muik, ... Emerging microbes & infections 11 (1), 1828-1832, 2022 | 39 | 2022 |
| Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth Z Ku, X Xie, J Lin, P Gao, B Wu, A El Sahili, H Su, Y Liu, X Ye, EY Tan, ... Nature communications 13 (1), 5552, 2022 | 31 | 2022 |
| Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein K Javanmardi, TH Segall-Shapiro, CW Chou, DR Boutz, RJ Olsen, X Xie, ... Cell host & microbe 30 (9), 1242-1254. e6, 2022 | 31 | 2022 |
| Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines L Wang, MH Kainulainen, N Jiang, H Di, G Bonenfant, L Mills, M Currier, ... Nature communications 13 (1), 4350, 2022 | 42 | 2022 |
| A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions Y Liu, X Zhang, J Liu, H Xia, J Zou, AE Muruato, S Periasamy, C Kurhade, ... Nature communications 13 (1), 4337, 2022 | 64 | 2022 |
| Neutralization of Omicron BA. 1, BA. 2, and BA. 3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine C Kurhade, J Zou, H Xia, H Cai, Q Yang, M Cutler, D Cooper, A Muik, ... Nature communications 13 (1), 3602, 2022 | 77 | 2022 |
| A single-round infection fluorescent SARS-CoV-2 neutralization test for COVID-19 serological testing at a biosafety level-2 laboratory J Zou, H Xia, PY Shi, X Xie, P Ren Viruses 14 (6), 1211, 2022 | 11 | 2022 |
| Cross-neutralization of Omicron BA. 1 against BA. 2 and BA. 3 SARS-CoV-2 J Zou, C Kurhade, H Xia, M Liu, X Xie, P Ren, PY Shi Nature communications 13 (1), 2956, 2022 | 28 | 2022 |
| Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant Y Liu, J Liu, BA Johnson, H Xia, Z Ku, C Schindewolf, SG Widen, Z An, ... Cell reports 39 (7), 2022 | 384 | 2022 |
| Viperin triggers ribosome collision-dependent translation inhibition to restrict viral replication JCC Hsu, M Laurent-Rolle, JB Pawlak, H Xia, A Kunte, JS Hee, J Lim, ... Molecular cell 82 (9), 1631-1642. e6, 2022 | 26 | 2022 |
| The E3-ligase TRIM7 acts as an antiviral factor by ubiquitinating the SARS-CoV-2 membrane protein to limit apoptosis and virus replication MJ Gonzalez Orozco, A Hage, H Xia, M Huante, S Van Tol, MI Giraldo, ... The Journal of Immunology 208 (1_Supplement), 51.07-51.07, 2022 | | 2022 |
| Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2 H Xia, J Zou, C Kurhade, H Cai, Q Yang, M Cutler, D Cooper, A Muik, ... Cell Host & Microbe 30 (4), 485-488. e3, 2022 | 86 | 2022 |
